e-learning
resources
Virtual 2020
Pre-Congress Content
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
C. Criée (Göttingen, Germany), S. Bahari Javan (Hamburg, Germany), G. Georges (Cary, United States of America), K. Melchior (Hamburg, Germany), R. Hövelmann (Hamburg, Germany), C. Geßner (Leipzig, Germany)
Source:
Virtual Congress 2020 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
E-poster session
Number:
2413
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Criée (Göttingen, Germany), S. Bahari Javan (Hamburg, Germany), G. Georges (Cary, United States of America), K. Melchior (Hamburg, Germany), R. Hövelmann (Hamburg, Germany), C. Geßner (Leipzig, Germany). Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.. 2413
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Short-term Impact of Lung Flute and Inspiratory Muscle Trainer on Pulmonary Functions and Functional Capacity in COPD from a Low Middle Income Country : A Pilot Randomized Control Trial.
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
Late Breaking Abstract - Abdominal Muscle Function During Spontaneous Breathing Trials to Predict Extubation Failure
Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation
Year: 2020
Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020
Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Effect of Vaping on Airway Barrier Function: A Pilot Study
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Resistance Training Alone Improves Lung Inflammation and Respiratory Muscle Strenght but not Lung Function and Mechanics in Mid-Age Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020
High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Oral presentation: A New Target and Novel Agent to Prevent Acute Lung Injury
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
Using HealthCare Failure Mode and Effect Analysis™:To Reduce Facial Pressure Injury of Non-invasive Positive Pressure Ventilation Patients.
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019
A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Functional Outcomes Long Term Survival and Surgical Risk After Lung Volume Reduction Surgery: A 12-year Single Center Experience.
Source: International Congress 2017 – Thoracic surgery: preoperative assessment, outcome and complications
Year: 2017
Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept